Cargando…
Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice
BACKGROUND: A robust evidence base is required to assist healthcare commissioners and providers in selecting effective and sustainable approaches to improve cancer diagnosis and treatment. Such evidence can be difficult to build, given the fast-paced and highly pressured nature of healthcare deliver...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619322/ https://www.ncbi.nlm.nih.gov/pubmed/37915009 http://dx.doi.org/10.1186/s12885-023-11592-w |
_version_ | 1785129963729453056 |
---|---|
author | Gadsby, Erica Wirrmann Brown, Carson Crawford, Claire Dale, Glen Duncan, Edward Galbraith, Linda Gold, Karen Hibberd, Carina McFarland, Agi McGlashan, Jennifer McInnes, Melanie McNaughton, Joanne Murray, Juliette Radin, Esme Teodorowski, Piotr Thomson, Jane |
author_facet | Gadsby, Erica Wirrmann Brown, Carson Crawford, Claire Dale, Glen Duncan, Edward Galbraith, Linda Gold, Karen Hibberd, Carina McFarland, Agi McGlashan, Jennifer McInnes, Melanie McNaughton, Joanne Murray, Juliette Radin, Esme Teodorowski, Piotr Thomson, Jane |
author_sort | Gadsby, Erica Wirrmann |
collection | PubMed |
description | BACKGROUND: A robust evidence base is required to assist healthcare commissioners and providers in selecting effective and sustainable approaches to improve cancer diagnosis and treatment. Such evidence can be difficult to build, given the fast-paced and highly pressured nature of healthcare delivery, the absence of incentives, and the presence of barriers in conducting pragmatic yet robust research evaluations. Cancer Research UK (CRUK) has played an active part in building the evidence base through its funding of programmes to identify, evaluate and scale-up innovative approaches across the UK. The aim of this paper is to describe and explain the research design and intended approach and activities for two cancer services improvement projects in Scotland funded by CRUK. METHODS: A hybrid effectiveness-implementation study design will assess both the efficiency of the new pathways and their implementation strategies, with the aim of generating knowledge for scale-up. A range of implementation, service and clinical outcomes will be assessed as determined by the projects’ Theories of Change (ToCs). A naturalistic case study approach will enable in-depth exploration of context and process, and the collection and synthesis of data from multiple sources including routine datasets, patient and staff surveys, in-depth interviews and observational and other data. The evaluations are informed throughout by a patient/public representatives’ group, and by small group discussions with volunteer cancer patients. DISCUSSION: Our approach has been designed to provide a holistic understanding of how (well) the improvement projects work (in relation to their anticipated outcomes), and how they interact with their wider contexts. The evaluations will help identify barriers, facilitators, and unanticipated consequences that can impact scalability, sustainability and spread. By opting for a pragmatic, participatory evaluation research design, we hope to inform strategies for scaling up successful innovations while addressing challenges in a targeted manner. |
format | Online Article Text |
id | pubmed-10619322 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106193222023-11-02 Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice Gadsby, Erica Wirrmann Brown, Carson Crawford, Claire Dale, Glen Duncan, Edward Galbraith, Linda Gold, Karen Hibberd, Carina McFarland, Agi McGlashan, Jennifer McInnes, Melanie McNaughton, Joanne Murray, Juliette Radin, Esme Teodorowski, Piotr Thomson, Jane BMC Cancer Study Protocol BACKGROUND: A robust evidence base is required to assist healthcare commissioners and providers in selecting effective and sustainable approaches to improve cancer diagnosis and treatment. Such evidence can be difficult to build, given the fast-paced and highly pressured nature of healthcare delivery, the absence of incentives, and the presence of barriers in conducting pragmatic yet robust research evaluations. Cancer Research UK (CRUK) has played an active part in building the evidence base through its funding of programmes to identify, evaluate and scale-up innovative approaches across the UK. The aim of this paper is to describe and explain the research design and intended approach and activities for two cancer services improvement projects in Scotland funded by CRUK. METHODS: A hybrid effectiveness-implementation study design will assess both the efficiency of the new pathways and their implementation strategies, with the aim of generating knowledge for scale-up. A range of implementation, service and clinical outcomes will be assessed as determined by the projects’ Theories of Change (ToCs). A naturalistic case study approach will enable in-depth exploration of context and process, and the collection and synthesis of data from multiple sources including routine datasets, patient and staff surveys, in-depth interviews and observational and other data. The evaluations are informed throughout by a patient/public representatives’ group, and by small group discussions with volunteer cancer patients. DISCUSSION: Our approach has been designed to provide a holistic understanding of how (well) the improvement projects work (in relation to their anticipated outcomes), and how they interact with their wider contexts. The evaluations will help identify barriers, facilitators, and unanticipated consequences that can impact scalability, sustainability and spread. By opting for a pragmatic, participatory evaluation research design, we hope to inform strategies for scaling up successful innovations while addressing challenges in a targeted manner. BioMed Central 2023-11-01 /pmc/articles/PMC10619322/ /pubmed/37915009 http://dx.doi.org/10.1186/s12885-023-11592-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Study Protocol Gadsby, Erica Wirrmann Brown, Carson Crawford, Claire Dale, Glen Duncan, Edward Galbraith, Linda Gold, Karen Hibberd, Carina McFarland, Agi McGlashan, Jennifer McInnes, Melanie McNaughton, Joanne Murray, Juliette Radin, Esme Teodorowski, Piotr Thomson, Jane Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice |
title | Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice |
title_full | Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice |
title_fullStr | Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice |
title_full_unstemmed | Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice |
title_short | Test, evidence, transition projects in Scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice |
title_sort | test, evidence, transition projects in scotland: developing the evidence needed for transition of effective interventions in cancer care from innovation into mainstream practice |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619322/ https://www.ncbi.nlm.nih.gov/pubmed/37915009 http://dx.doi.org/10.1186/s12885-023-11592-w |
work_keys_str_mv | AT gadsbyericawirrmann testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT browncarson testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT crawfordclaire testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT daleglen testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT duncanedward testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT galbraithlinda testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT goldkaren testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT hibberdcarina testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT mcfarlandagi testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT mcglashanjennifer testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT mcinnesmelanie testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT mcnaughtonjoanne testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT murrayjuliette testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT radinesme testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT teodorowskipiotr testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice AT thomsonjane testevidencetransitionprojectsinscotlanddevelopingtheevidenceneededfortransitionofeffectiveinterventionsincancercarefrominnovationintomainstreampractice |